Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Travere Therapeutics, Inc. - Common Stock (NQ:TVTX)

35.21 +0.48 (+1.38%)
Streaming Delayed Price Updated: 2:55 PM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Travere Therapeutics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Mid-Afternoon Market Update: Build-A-Bear Rises After Q1 Results; Travere Therapeutics Shares Drop ↗
Toward the end of trading Wednesday, the Dow traded up 0.06% to 34,333.12 while the NASDAQ rose 0.53% to 13,728.97. The S&P also rose, gaining 0.18% to 4,195.77. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Wednesday morning, 20 companies set new 52-week lows. Interesting Facts: The largest company in terms of market cap to set a new 52-week low was Ionis... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 5.4... 
Via Benzinga
News headline image
41 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Asensus Surgical, Inc. (NYSE: ASXC) shares surged 34.4% to $2.7282. HC Wainwright & Co. initiated coverage on Asensus Surgical with a Buy rating and announced a price... 
Via Benzinga
News headline image
Mid-Day Market Update: Nasdaq Surges 70 Points; Larimar Therapeutics Shares Plummet ↗
Midway through trading Wednesday, the Dow traded up 0.13% to 34,358.03 while the NASDAQ rose 0.52% to 13,728.18. The S&P also rose, gaining 0.19% to 4,195.92. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Mid-Morning Market Update: Markets Mixed; Dick's Sporting Goods Beats Q1 Estimates ↗
Following the market opening Wednesday, the Dow traded down 0.05% to 34,295.72 while the NASDAQ rose 0.26% to 13,692.86. The S&P also fell, dropping 0.03% to 4,186.92. The U.S... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2021 ↗
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021 ↗
Upgrades Bernstein upgraded the previous rating for Wipro Ltd (NYSE:WIT) from Underperform to Market Perform. Wipro earned $0.07 in the fourth quarter, compared to $0.05... 
Via Benzinga
News headline image
22 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial... 
Via Benzinga
News headline image
Retrophin Earnings Preview ↗
On Thursday, May 06, Retrophin (NASDAQ:TVTX) will release its latest earnings report. Check out Benzinga's preview to understand the implications. What Are Earnings, Net Income,... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Travere Therapeutics' Sparsentan Program Submission Pushed to 2022; FDA Requires More Data ↗
Following the pre-NDA meeting, the FDA has asked Travere Therapeutics Inc (NASDAQ: TVTX) to submit additional data for the sparsentan program in focal... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
News headline image
70 Biggest Movers From Friday ↗
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.